Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
4,263,270
-
Share change
-
-946,625
-
Total reported value
-
$12,878,997
-
Put/Call ratio
-
0.13%
-
Price per share
-
$3.02
-
Number of holders
-
35
-
Value change
-
-$3,370,234
-
Number of buys
-
19
-
Number of sells
-
15
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q4 2024
As of 31 Dec 2024,
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,263,270 shares.
The largest 10 holders included
KINGDON CAPITAL MANAGEMENT, L.L.C., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Altium Capital Management LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), JPMORGAN CHASE & CO, Alyeska Investment Group, L.P., Westside Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.